PETQ - ペットIQ （PetIQ Inc.）

EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.

PetIQ is a company operating in a very large market, the pet care and health industry. Read more about PETQ here.

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook

PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com

EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.

PetIQ is a company operating in a very large market, the pet care and health industry. Read more about PETQ here.

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook

PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook

PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close.

PetIQ''s manufactured products saw exceptional performance in Q3. Read more to see why we rate PETQ stock a buy.